https://www.selleckchem.com/pr....oducts/pexidartinib-
ol-related cirrhosis abstain from alcohol and improve their health. Wider use of these interventions should be encouraged. Alcohol use treatments, including physician counseling and medication-assisted therapies (MATs), improve the outcomes of patients with compensated alcohol-related cirrhosis, though use and access have remained suboptimal. In this study, we found that counseling and MATs are extremely cost-effective, and in some cases cost-saving, interventions to help patients with alcohol-related cirrhosis abstain from